CHHHF:OTC-CareRx Corporation (USD)

COMMON STOCK | Medical Care Facilities | OTC

Last Closing Price

USD 5.49

Change

0.00 (0.00)%

Market Cap

USD 0.15B

Average Target Price

USD 8.67 (+57.86%)
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict

About

CareRx Corporation, together with its subsidiaries, provides specialty pharmacy services to seniors in Canada. The company operates a network of pharmacy fulfilment centers that provide chronic medication and other specialty clinical pharmacy services. It serves approximately 50,000 residents in approximately 900 seniors and other communities, including long-term care homes, retirement homes, assisted living facilities, and group homes. The company was formerly known as Centric Health Corporation and changed its name to CareRx Corporation in June 2020. CareRx Corporation was incorporated in 2001 and is headquartered in Toronto, Canada.

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2021-06-13 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
FSNUY Fresenius SE & Co. KGaA

N/A

USD36.51B 14.95 9.41
FSNUF Fresenius SE & Co. KGaA

N/A

USD36.51B 13.75 9.41
FMCQF Fresenius Medical Care AG & Co..

N/A

USD24.34B 17.69 9.58
SKHHY Sonic Healthcare Limited

N/A

USD13.18B 17.79 7.46
SKHCF Sonic Healthcare Limited

N/A

USD13.18B 17.74 7.46
IHHHF IHH Healthcare Berhad

N/A

USD11.68B 47.64 3.95
BDUUY Bangkok Dusit Medical Services..

N/A

USD11.62B 38.97 0.72
BDULF Bangkok Dusit Medical Services..

N/A

USD11.62B 59.89 0.72
BDUUF Bangkok Dusit Medical Services..

N/A

USD11.61B 62.50 0.72
RMYHY Ramsay Health Care Limited

N/A

USD11.28B 58.32 10.91

ETFs Containing CHHHF

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Medical Care Facilities)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 66.36% N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 66.36% N/A N/A N/A N/A
Trailing 12 Months  
Capital Gain 83.00% N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 83.00% N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -7.53% 26% F 16% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -7.53% 24% F 14% F
Risk Return Profile  
Volatility (Standard Deviation) 45.70% 56% F 51% F
Risk Adjusted Return -16.47% 26% F 19% F
Market Capitalization 0.15B N/A N/A N/A N/A
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Medical Care Facilities)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 11.40 N/A N/A N/A N/A
Price/Book Ratio 6.70 N/A N/A N/A N/A
Price / Cash Flow Ratio 652.38 N/A N/A N/A N/A
EV/EBITDA 14.69 N/A N/A N/A N/A
Management Effectiveness  
Return on Equity -417.82% N/A N/A N/A N/A
Return on Invested Capital -1.74% N/A N/A N/A N/A
Return on Assets 0.02% N/A N/A N/A N/A
Debt to Equity Ratio 636.54% N/A N/A N/A N/A
Technical Ratios  
Short Ratio N/A N/A N/A N/A N/A
Short Percent N/A N/A N/A N/A N/A
Beta 0.76 N/A N/A N/A N/A
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.